Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNCB
3126
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $295K | ﹤0.01% |
47,621
+20,875
| +78% | +$160K |
|
|
HALL
3127
DELISTED
Hallmark Financial Services, Inc.
HALL
| $292K | ﹤0.01% |
+44,951
| New | +$371K |
|
3128
Monte Rosa Therapeutics
GLUE
$1.35B
| $290K | ﹤0.01% |
+37,268
| New | +$259K |
|
3129
Cytosorbents Corp
CTSO
$22.7M
| $290K | ﹤0.01% |
86,016
-7,263
| -8% | -$21.8K |
|
|
SWKH
3130
DELISTED
SWK Holdings
SWKH
| $290K | ﹤0.01% |
20,473
+166
| +0.8% | +$2.44K |
|
|
AYX
3131
DELISTED
Alteryx Inc
AYX
| $289K | ﹤0.01% |
4,918
| – | – |
|
|
INZY
3132
DELISTED
Inozyme Pharma
INZY
| $287K | ﹤0.01% |
50,577
+28,370
| +128% | +$75K |
|
3133
Pathfinder Bancorp
PBHC
$101M
| $285K | ﹤0.01% |
16,517
| – | – |
|
|
FORTY
3134
Formula Systems
FORTY
$1.63B
| $283K | ﹤0.01% |
4,303
| – | – |
|
3135
Karat Packaging
KRT
$808M
| $282K | ﹤0.01% |
+21,154
| New | +$313K |
|
3136
CKX Lands
CKX
| $282K | ﹤0.01% |
29,876
-1,142
| -4% | -$11.2K |
|
3137
Stereotaxis
STXS
$127M
| $279K | ﹤0.01% |
136,959
-10,559
| -7% | -$23.7K |
|
3138
Ring Energy
REI
$317M
| $279K | ﹤0.01% |
146,899
| – | – |
|
|
SPPI
3139
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $279K | ﹤0.01% |
371,792
-67,931
| -15% | -$49.6K |
|
3140
Viridian Therapeutics
VRDN
$2.1B
| $278K | ﹤0.01% |
10,926
-472
| -4% | -$15.1K |
|
|
SUNE
3141
SUNation Energy
SUNE
$9.36M
| $278K | ﹤0.01% |
1
| – | – |
|
3142
Paymentus
PAY
$4.31B
| $276K | ﹤0.01% |
+31,186
| New | +$263K |
|
3143
Great Elm Group
GEG
$69M
| $274K | ﹤0.01% |
120,736
| – | – |
|
3144
Smart Sand
SND
$186M
| $274K | ﹤0.01% |
155,694
-17,769
| -10% | -$33K |
|
|
SYBX
3145
DELISTED
Synlogic
SYBX
| $274K | ﹤0.01% |
28,888
-2,524
| -8% | -$30K |
|
3146
Lake Shore Bancorp
LSBK
$135M
| $272K | ﹤0.01% |
26,934
+1,707
| +7% | +$19.9K |
|
3147
Acumen Pharmaceuticals
ABOS
$155M
| $271K | ﹤0.01% |
+66,779
| New | +$349K |
|
3148
DarioHealth
DRIO
$68.3M
| $267K | ﹤0.01% |
3,244
+62
| +2% | +$6.09K |
|
3149
Solid Biosciences
SLDB
$796M
| $267K | ﹤0.01% |
56,335
+597
| +1% | +$3.59K |
|
|
HCP
3150
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $266K | ﹤0.01% |
9,088
+1,172
| +15% | +$35K |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.